Related references
Note: Only part of the references are listed.Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review
Susanne Wiegand et al.
LYMPHATIC RESEARCH AND BIOLOGY (2018)
Etiology and Genetics of Congenital Vascular Lesions
Angela Queisser et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2018)
Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review
Susanne Wiegand et al.
LYMPHATIC RESEARCH AND BIOLOGY (2018)
Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract
Peter Baluk et al.
JCI INSIGHT (2017)
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review
Marion Nadal et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease
Michio Ozeki et al.
PEDIATRIC BLOOD & CANCER (2016)
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Denise M. Adams et al.
PEDIATRICS (2016)
Sirolimus for the treatment of children with various complicated vascular anomalies
Herwig Lackner et al.
EUROPEAN JOURNAL OF PEDIATRICS (2015)
AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation
Elisa Boscolo et al.
ANGIOGENESIS (2015)
Genetics of lymphatic anomalies
Pascal Brouillard et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Complex lymphatic anomalies
Cameron C. Trenor et al.
SEMINARS IN PEDIATRIC SURGERY (2014)
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
Patrick F. Fogarty et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Rapamycin Inhibits Lymphatic Endothelial Cell Tube Formation by Downregulating Vascular Endothelial Growth Factor Receptor 3 Protein Expression
Yan Luo et al.
NEOPLASIA (2012)
Sirolimus for the Treatment of Complicated Vascular Anomalies in Children
Adrienne M. Hammill et al.
PEDIATRIC BLOOD & CANCER (2011)
Visualization of Embryonic Lymphangiogenesis Advances the Use of the Zebrafish Model for Research in Cancer and Lymphatic Pathologies
Maria Vega Flores et al.
DEVELOPMENTAL DYNAMICS (2010)
Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis
Soichi Kobayashi et al.
CANCER SCIENCE (2007)
Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis
S. Huber et al.
KIDNEY INTERNATIONAL (2007)
PedsQL™ 4.0:: Reliability and validity of the pediatric quality of life Inventory™ Version 4.0 generic core scales in healthy and patient populations
JW Varni et al.
MEDICAL CARE (2001)
Share Paper
